Enoxaparin sodium biosimilar (Apotex Pty Ltd)

依诺肝素钠生物类似药（Apotex Pty Ltd）

Report date: 2022/01/20 09:29:30

Base Information

Drug NameEnoxaparin sodium biosimilar (Apotex Pty Ltd)
Drug Alias Name依诺肝素钠生物仿制药（Apotex Pty Ltd）ENOXAPOClexane biosimilar - Apotex Pty LtdEnoxaparin sodium biosimilar - Apotex Pty Ltd
ClassificationBiologics > Biosimilar
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIICoagulation factor XProthrombin
Therapy Area/IndicationsVenous ThrombosisThrombosisVenous Thromboembolism +[5] 
Global Approved IndicationsVenous ThrombosisThrombosisVenous Thromboembolism +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustralia
Original Approved Date2020/02/10
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesApotex
China Registration ClassN/A

Develop Information

Active CompaniesApotex
Inactive CompaniesN/A
Active IndicationsVenous ThrombosisThrombosisVenous Thromboembolism +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeB01AB05
Related LinksN/A